NIFTY 50

Glenmark Pharma Q3 earnings: Here’s what you can expect

Updated : February 14, 2020 02:10 PM IST

Glenmark Pharma is expected to report its Q3 earnings on Friday. The company is expected to report single-digit revenue growth at around 4.7 percent. Margins could be under pressure and 15.5 percent is what the street is expecting with a profit of around Rs 177 crore.

Single-digit revenue growth is expected on account of sluggish US sales. In the last quarter, there was an increase of around $16 million on quarter-on-quarter (QoQ) basis in US sales. But in this quarter, the expectation is that there could be a decline of around $10 million on QoQ basis owing to price competition.

In terms of the India portfolio, the business is expected to be steady and see a growth of 12 percent.
primo org
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more
Live TV